Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?

[1]  M. Goldoni,et al.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson’s disease , 2014, Journal of Neural Transmission.

[2]  Yuichi Inoue,et al.  The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. , 2013, Sleep medicine.

[3]  U. Muthane,et al.  Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study. , 2013, Parkinsonism & related disorders.

[4]  S. Yagi,et al.  In vivo Mesolimbic D2/3 Receptor Binding Predicts Posttherapeutic Clinical Responses in Restless Legs Syndrome: A Positron Emission Tomography Study , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  A. Negrotti,et al.  A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: Absence of co-morbid association , 2011, Journal of the Neurological Sciences.

[6]  W. Ondo,et al.  Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. , 2011, Sleep medicine.

[7]  L. Chahine,et al.  Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. , 2011, Parkinsonism & related disorders.

[8]  Y. Kang,et al.  Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta , 2011, Journal of neurochemistry.

[9]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[10]  S. V. van Rooden,et al.  Prevalence and clinical profile of restless legs syndrome in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[11]  D. Garcia-Borreguero,et al.  Dopaminergic augmentation of restless legs syndrome. , 2010, Sleep medicine reviews.

[12]  W. Paulus,et al.  Restless legs syndrome: pathophysiology, clinical presentation and management , 2010, Nature Reviews Neurology.

[13]  Y. Sohn,et al.  Factors contributing to the development of restless legs syndrome in patients with Parkinson disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Negrotti,et al.  Absence of co-morbidity of Parkinson disease and restless legs syndrome: a case–control study in patients attending a movement disorders clinic , 2009, Neurological Sciences.

[15]  E. Tan,et al.  Case–control study of restless legs syndrome and quality of sleep in Parkinson's disease , 2008, Journal of the Neurological Sciences.

[16]  Lemlih Ouchchane,et al.  Brain mapping in stereotactic surgery: A brief overview from the probabilistic targeting to the patient-based anatomic mapping , 2007, NeuroImage.

[17]  A. Walters,et al.  Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. , 2007, Sleep medicine.

[18]  W. Ondo,et al.  Spinal cord dopamine receptor expression and function in mice with 6‐OHDA lesion of the A11 nucleus and dietary iron deprivation , 2007, Journal of neuroscience research.

[19]  K. Nakashima,et al.  Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease , 2006, Journal of the Neurological Sciences.

[20]  W. Paulus,et al.  Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome , 2006, The Lancet Neurology.

[21]  C. Adler,et al.  Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation , 2006, Movement disorders : official journal of the Movement Disorder Society.

[22]  C. Halldin,et al.  Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. , 2006, Brain : a journal of neurology.

[23]  K. Nakashima,et al.  Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[24]  S. Thobois.  Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. , 2006, Clinical therapeutics.

[25]  A. Lang,et al.  Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease , 2004, Neurology.

[26]  S. Hochman,et al.  Conversion of the Modulatory Actions of Dopamine on Spinal Reflexes from Depression to Facilitation in D3 Receptor Knock-Out Mice , 2004, The Journal of Neuroscience.

[27]  D. Rye.  Parkinson's disease and RLS: the dopaminergic bridge. , 2004, Sleep medicine.

[28]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[29]  P. Riederer,et al.  Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum , 2003, Journal of Neural Transmission.

[30]  Richard P Allen,et al.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.

[31]  M. Behari,et al.  Restless legs syndrome in Parkinson's disease: A case‐controlled study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[32]  Richard P Allen,et al.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. , 2003, Sleep medicine.

[33]  R. Feise.  Do multiple outcome measures require p-value adjustment? , 2002, BMC medical research methodology.

[34]  E. Tan,et al.  Restless legs syndrome in Parkinson's disease , 2002, Journal of the Neurological Sciences.

[35]  J. Jankovic,et al.  Exploring the relationship between Parkinson disease and restless legs syndrome. , 2002, Archives of neurology.

[36]  R. Malenka,et al.  Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. , 2000, Annual review of neuroscience.

[37]  W. Ondo,et al.  Clinical correlates of 6‐hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome? , 2000, Movement disorders : official journal of the Movement Disorder Society.

[38]  R P Allen,et al.  Augmentation of the restless legs syndrome with carbidopa/levodopa. , 1996, Sleep.

[39]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[40]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[41]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[42]  C. Duyckaerts,et al.  Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients , 1986, Brain Research.

[43]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[44]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.